Acurx Pharmaceuticals Inc (ACXP)
1.77
-0.04
(-2.21%)
USD |
NASDAQ |
Nov 14, 12:39
Acurx Pharmaceuticals Shareholders Equity (Quarterly): 3.428M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.428M |
| March 31, 2024 | 5.999M |
| December 31, 2023 | 4.667M |
| September 30, 2023 | 3.935M |
| June 30, 2023 | 6.216M |
| March 31, 2023 | 5.311M |
| December 31, 2022 | 7.315M |
| September 30, 2022 | 9.763M |
| Date | Value |
|---|---|
| June 30, 2022 | 8.785M |
| March 31, 2022 | 10.69M |
| December 31, 2021 | 12.41M |
| September 30, 2021 | 14.28M |
| June 30, 2021 | 15.52M |
| March 31, 2021 | 2.471M |
| December 31, 2020 | 2.702M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.471M
Minimum
Mar 2021
15.52M
Maximum
Jun 2021
7.566M
Average
6.216M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Modular Medical Inc | 8.016M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.580M |
| Total Liabilities (Quarterly) | 3.153M |